Intellectual Property

Intellectual Property

The protection of our proprietary technology and products through patents and other enforceable intellectual property rights that we own or license is a key to our business and competitive position.
 
As of January 1, 2016, Foamix has over 138 issued patents worldwide, including 45 in the United States, together with over 80 pending patent applications worldwide.
 
Our lead products FMX101, FMX102 and FDX104 are covered by an issued U.S. patent, which is expected to remain in effect until 2030.
 
The following trademarks are registered in the U.S.: Foamix®, FOAMIX®, License to Foam®, U-foam®, ,Acyclofoam®, PerFoam®, Metro Mousse®, Topimousse®, Foamix24®, Fastreat® and Foamedic®.